Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 2
1997 2
1998 2
1999 1
2000 4
2002 3
2003 5
2004 6
2005 2
2006 1
2007 6
2008 1
2009 7
2010 6
2011 3
2012 5
2013 6
2014 5
2015 4
2016 2
2017 3
2018 3
2019 7
2020 6
2021 10
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

94 results
Results by year
Filters applied: . Clear all
Page 1
Prodrugs in genetic chemoradiotherapy.
Patterson AV, Saunders MP, Greco O. Patterson AV, et al. Curr Pharm Des. 2003;9(26):2131-54. doi: 10.2174/1381612033454117. Curr Pharm Des. 2003. PMID: 14529410 Review.
Bioreductive prodrugs as cancer therapeutics: targeting tumor hypoxia.
Guise CP, Mowday AM, Ashoorzadeh A, Yuan R, Lin WH, Wu DH, Smaill JB, Patterson AV, Ding K. Guise CP, et al. Among authors: patterson av. Chin J Cancer. 2014 Feb;33(2):80-6. doi: 10.5732/cjc.012.10285. Epub 2013 Jul 12. Chin J Cancer. 2014. PMID: 23845143 Free PMC article. Review.
Advancing Clostridia to Clinical Trial: Past Lessons and Recent Progress.
Mowday AM, Guise CP, Ackerley DF, Minton NP, Lambin P, Dubois LJ, Theys J, Smaill JB, Patterson AV. Mowday AM, et al. Among authors: patterson av. Cancers (Basel). 2016 Jun 28;8(7):63. doi: 10.3390/cancers8070063. Cancers (Basel). 2016. PMID: 27367731 Free PMC article. Review.
Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506.
van der Wiel AMA, Jackson-Patel V, Niemans R, Yaromina A, Liu E, Marcus D, Mowday AM, Lieuwes NG, Biemans R, Lin X, Fu Z, Kumara S, Jochems A, Ashoorzadeh A, Anderson RF, Hicks KO, Bull MR, Abbattista MR, Guise CP, Deschoemaeker S, Thiolloy S, Heyerick A, Solivio MJ, Balbo S, Smaill JB, Theys J, Dubois LJ, Patterson AV, Lambin P. van der Wiel AMA, et al. Among authors: patterson av. Mol Cancer Ther. 2021 Dec;20(12):2372-2383. doi: 10.1158/1535-7163.MCT-21-0406. Epub 2021 Oct 8. Mol Cancer Ther. 2021. PMID: 34625504 Free article.
Bystander or no bystander for gene directed enzyme prodrug therapy.
Dachs GU, Hunt MA, Syddall S, Singleton DC, Patterson AV. Dachs GU, et al. Among authors: patterson av. Molecules. 2009 Nov 10;14(11):4517-45. doi: 10.3390/molecules14114517. Molecules. 2009. PMID: 19924084 Free PMC article. Review.
94 results